APA (7th ed.) Citation

Korell, F., Schubert, M., Sauer, T., Schmitt, A., Derigs, P., Weber, T. F., . . . Pabst, T. (2021). Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma. Cancers, 13(7), 1684. https://doi.org/10.3390/cancers13071684

Chicago Style (17th ed.) Citation

Korell, Felix, et al. "Infection Complications After Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma." Cancers 13, no. 7 (2021): 1684. https://doi.org/10.3390/cancers13071684.

MLA (9th ed.) Citation

Korell, Felix, et al. "Infection Complications After Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma." Cancers, vol. 13, no. 7, 2021, p. 1684, https://doi.org/10.3390/cancers13071684.